Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Harlan S Robins. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Harlan S Robins har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ADPT / Adaptive Biotechnologies Corporation | Chief Scientific Officer | 1 279 524 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Harlan S Robins. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ADPT / Adaptive Biotechnologies Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ADPT / Adaptive Biotechnologies Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ADPT / Adaptive Biotechnologies Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Harlan S Robins som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −68 412 | 1 279 524 | −5,08 | 7,35 | −502 828 | 9 404 501 |
2025-05-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 68 412 | 1 347 936 | 5,35 | 6,32 | 432 364 | 8 518 956 |
2025-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 698 | 1 279 524 | −0,13 | 9,00 | −15 282 | 11 515 716 |
2025-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 1 698 | 1 281 222 | 0,13 | 6,32 | 10 731 | 8 097 323 |
2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −56 053 | 1 279 524 | −4,20 | 6,99 | −391 810 | 8 943 873 | |
2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −40 603 | 1 335 577 | −2,95 | 6,98 | −283 409 | 9 322 327 | |
2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 355 000 | 1 376 180 | 34,76 | ||||
2024-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 354 610 | 1 021 180 | 53,20 | ||||
2023-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 354 610 | 666 570 | 113,67 | ||||
2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −4 517 | 311 960 | −1,43 | 12,01 | −54 249 | 3 746 640 | |
2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 617 792 | 617 792 | |||||
2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 247 117 | 316 477 | 356,28 | ||||
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −300 | 284 800 | −0,11 | |||
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −300 | 69 360 | −0,43 | 31,36 | −9 408 | 2 175 130 |
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 300 | 69 660 | 0,43 | 6,55 | 1 965 | 456 273 |
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 285 100 | −1,28 | |||
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 700 | 69 360 | −5,06 | 32,05 | −118 585 | 2 222 988 |
2021-11-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 73 060 | 5,33 | 6,55 | 24 235 | 478 543 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 288 800 | −1,26 | |||
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 700 | 69 360 | −5,06 | 33,73 | −124 801 | 2 339 513 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 73 060 | 5,33 | 6,55 | 24 235 | 478 543 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 292 500 | −1,25 | |||
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 700 | 69 360 | −5,06 | 33,71 | −124 727 | 2 338 126 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 73 060 | 5,33 | 6,55 | 24 235 | 478 543 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 800 | 296 200 | −1,27 | |||
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 500 | 69 360 | −4,80 | 33,76 | −118 160 | 2 341 594 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −300 | 72 860 | −0,41 | 32,91 | −9 873 | 2 397 823 |
2021-10-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 800 | 73 160 | 5,48 | 6,55 | 24 890 | 479 198 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 70 110 | −5,26 | |||
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 32,96 | −128 379 | 2 286 106 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 74 005 | −5,00 | |||
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 695 | 69 360 | −5,06 | 33,68 | −124 448 | 2 336 045 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −200 | 73 055 | −0,27 | 32,50 | −6 500 | 2 374 288 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 77 900 | −4,76 | |||
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 32,27 | −125 692 | 2 238 247 |
2021-10-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 81 795 | −4,55 | |||
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −900 | 69 360 | −1,28 | 37,23 | −33 507 | 2 582 273 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 995 | 70 260 | −4,09 | 36,52 | −109 377 | 2 565 895 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 85 690 | −4,35 | |||
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 100 | 69 360 | −1,56 | 37,36 | −41 096 | 2 591 290 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 795 | 70 460 | −3,82 | 36,49 | −101 990 | 2 571 085 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 89 585 | −4,17 | |||
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −900 | 69 360 | −1,28 | 37,89 | −34 101 | 2 628 050 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 995 | 70 260 | −4,09 | 37,39 | −111 983 | 2 627 021 |
2021-09-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 93 480 | −4,00 | |||
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 934 | 69 360 | −4,06 | 34,97 | −102 602 | 2 425 519 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −961 | 72 294 | −1,31 | 34,18 | −32 847 | 2 471 009 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 97 375 | −3,85 | |||
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 33,89 | −132 002 | 2 350 610 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 101 270 | −3,70 | |||
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 34,09 | −132 781 | 2 364 482 |
2021-08-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 105 165 | −3,57 | |||
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 495 | 69 360 | −3,47 | 38,11 | −95 084 | 2 643 310 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 400 | 71 855 | −1,91 | 37,29 | −52 206 | 2 679 473 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 109 060 | −3,45 | |||
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 595 | 69 360 | −3,61 | 37,82 | −98 143 | 2 623 195 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 300 | 71 955 | −1,77 | 36,81 | −47 853 | 2 648 664 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 112 955 | −3,33 | |||
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 622 | 69 360 | −3,64 | 37,33 | −97 879 | 2 589 209 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 273 | 71 982 | −1,74 | 36,70 | −46 719 | 2 641 739 |
2021-07-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 128 535 | −2,94 | |||
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −847 | 69 360 | −1,21 | 36,38 | −30 814 | 2 523 317 |
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 048 | 70 207 | −4,16 | 35,51 | −108 234 | 2 493 051 |
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 132 430 | −2,86 | |||
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 35,43 | −138 000 | 2 457 425 |
2021-06-11 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 116 850 | −3,23 | |||
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 895 | 69 360 | −5,32 | 38,41 | −149 607 | 2 664 118 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 120 745 | −3,12 | |||
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 795 | 69 360 | −3,87 | 37,87 | −105 847 | 2 626 663 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 100 | 72 155 | −1,50 | 36,77 | −40 447 | 2 653 139 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 124 640 | −3,03 | |||
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −500 | 69 360 | −0,72 | 36,50 | −18 250 | 2 531 640 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 395 | 69 860 | −4,63 | 35,91 | −121 914 | 2 508 673 |
2021-06-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 128 535 | −2,94 | |||
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −847 | 69 360 | −1,21 | 36,38 | −30 814 | 2 523 317 |
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 048 | 70 207 | −4,16 | 35,51 | −108 234 | 2 493 051 |
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 132 430 | −2,86 | |||
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 195 | 69 360 | −4,40 | 35,43 | −113 199 | 2 457 425 |
2021-05-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-05-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 895 | 136 325 | −2,78 | |||
2021-05-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −700 | 69 360 | −1,00 | 36,80 | −25 760 | 2 552 448 |
2021-05-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 195 | 70 060 | −4,36 | 35,99 | −114 988 | 2 521 459 |
2021-05-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 895 | 73 255 | 5,62 | 6,32 | 24 616 | 462 972 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 140 220 | −5,26 | |||
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 510 | 69 360 | −4,82 | 43,59 | −153 001 | 3 023 402 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 280 | 72 870 | −5,55 | 42,85 | −183 398 | 3 122 480 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 77 150 | 11,23 | 6,32 | 49 233 | 487 588 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 148 010 | −5,00 | |||
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 200 | 69 360 | −6,97 | 41,79 | −217 308 | 2 898 554 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 090 | 74 560 | −2,73 | 41,17 | −86 045 | 3 069 635 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −500 | 76 650 | −0,65 | 39,85 | −19 925 | 3 054 502 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 77 150 | 11,23 | 6,32 | 49 233 | 487 588 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 685 | 155 800 | −6,98 | |||
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 000 | 69 360 | −4,15 | 41,35 | −124 050 | 2 868 036 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 685 | 72 360 | −10,72 | 40,24 | −349 484 | 2 911 766 |
2021-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 685 | 81 045 | 16,85 | 6,32 | 73 849 | 512 204 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −5 290 | 167 485 | −3,06 | |||
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 481 | 69 360 | −2,09 | 38,72 | −57 344 | 2 685 619 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 809 | 70 841 | −5,10 | 38,13 | −145 237 | 2 701 167 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 5 290 | 74 650 | 7,63 | 6,32 | 33 433 | 471 788 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −6 395 | 172 775 | −3,57 | |||
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −400 | 69 360 | −0,57 | 41,76 | −16 704 | 2 896 474 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 175 | 69 760 | −5,65 | 40,33 | −168 378 | 2 813 421 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 820 | 73 935 | −2,40 | 39,43 | −71 763 | 2 915 257 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 6 395 | 75 755 | 9,22 | 6,32 | 40 416 | 478 772 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 179 170 | −4,17 | |||
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 790 | 69 360 | −10,10 | 41,93 | −326 635 | 2 908 265 |
2021-03-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 77 150 | 11,23 | 6,32 | 49 233 | 487 588 |
2021-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 171 703 | 171 703 | |||||
2021-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 68 681 | 69 360 | 10 115,02 | ||||
2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 186 960 | −4,00 | |||
2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −860 | 679 | −55,88 | 60,34 | −51 892 | 40 971 |
2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 930 | 1 539 | −81,83 | 59,49 | −412 266 | 91 555 |
2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 8 469 | 1 147,28 | 6,32 | 49 233 | 53 524 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 194 750 | −3,85 | |||
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 379 | 679 | −77,80 | 60,57 | −144 096 | 41 127 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 501 | 3 058 | −44,99 | 59,80 | −149 560 | 182 868 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 910 | 5 559 | −34,36 | 58,76 | −170 992 | 326 647 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 8 469 | 1 147,28 | 6,32 | 49 233 | 53 524 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 790 | 202 540 | −3,70 | |||
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 590 | 679 | −84,09 | 56,18 | −201 686 | 38 146 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 200 | 4 269 | −49,59 | 55,54 | −233 268 | 237 100 |
2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 790 | 8 469 | 1 147,28 | 6,32 | 49 233 | 53 524 |
2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −23 370 | 210 330 | −10,00 | |||
2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 100 | 679 | −75,57 | 67,59 | −141 939 | 45 894 |
2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −17 329 | 2 779 | −86,18 | 66,90 | −1 159 310 | 185 915 |
2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 941 | 20 108 | −16,39 | 66,06 | −260 342 | 1 328 334 |
2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 23 370 | 24 049 | 3 441,83 | 6,32 | 147 698 | 151 990 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 661 | 679 | −87,28 | 68,20 | −317 880 | 46 308 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −24 945 | 5 340 | −82,37 | 67,39 | −1 681 044 | 359 863 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −20 394 | 30 285 | −40,24 | 66,84 | −1 363 135 | 2 024 249 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 50 000 | 50 679 | 7 363,77 | 6,55 | 327 500 | 331 947 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 100 | 679 | −75,57 | 70,75 | −148 575 | 48 039 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 052 | 2 779 | −74,34 | 69,97 | −563 398 | 194 447 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 701 | 10 831 | −34,48 | 69,26 | −394 851 | 750 155 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 001 | 16 532 | −15,36 | 67,74 | −203 288 | 1 119 878 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −31 146 | 19 533 | −61,46 | 67,02 | −2 087 405 | 1 309 102 |
2021-01-25 |
|
4/A | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 50 000 | 50 679 | 7 363,77 | 6,55 | 327 500 | 331 947 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 133 700 | −27,22 | |||
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 661 | 679 | −87,28 | 68,20 | −317 880 | 46 308 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −24 945 | 5 340 | −82,37 | 67,39 | −1 681 044 | 359 863 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −20 394 | 30 285 | −40,24 | 66,84 | −1 363 135 | 2 024 249 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 50 000 | 50 679 | 7 363,77 | 6,32 | 316 000 | 320 291 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 183 700 | −21,39 | |||
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 100 | 679 | −75,57 | 70,75 | −148 575 | 48 039 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 052 | 2 779 | −74,34 | 69,97 | −563 398 | 194 447 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 701 | 10 831 | −34,48 | 69,26 | −394 851 | 750 155 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 001 | 16 532 | −15,36 | 67,74 | −203 288 | 1 119 878 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −31 146 | 19 533 | −61,46 | 67,02 | −2 087 405 | 1 309 102 |
2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 50 000 | 50 679 | 7 363,77 | 6,32 | 316 000 | 320 291 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 233 700 | −4,53 | |||
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −900 | 679 | −57,00 | 52,50 | −47 250 | 35 648 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 700 | 1 579 | −84,64 | 51,57 | −448 659 | 81 429 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 500 | 10 279 | −12,73 | 50,48 | −75 720 | 518 884 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 244 800 | −4,34 | |||
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 846 | 679 | −84,99 | 50,88 | −195 684 | 34 548 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 254 | 4 525 | −61,58 | 50,00 | −362 700 | 226 250 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 255 900 | −4,16 | |||
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 300 | 679 | −65,69 | 50,98 | −66 274 | 34 615 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 800 | 1 979 | −83,20 | 50,20 | −491 960 | 99 346 |
2020-11-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-10-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 267 000 | −3,99 | |||
2020-10-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −11 100 | 679 | −94,24 | 51,79 | −574 869 | 35 165 |
2020-10-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 278 100 | −3,84 | |||
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −11 100 | 679 | −94,24 | 51,55 | −572 205 | 35 002 |
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 289 200 | −3,70 | |||
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 480 | 679 | −83,67 | 52,84 | −183 883 | 35 878 |
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 620 | 4 159 | −64,69 | 51,87 | −395 249 | 215 727 |
2020-10-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 300 300 | −3,56 | |||
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 900 | 679 | −85,17 | 47,98 | −187 122 | 32 578 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 560 | 4 579 | −43,74 | 47,28 | −168 317 | 216 495 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 640 | 8 139 | −30,90 | 46,00 | −167 440 | 374 394 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 311 400 | −3,44 | |||
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −11 100 | 679 | −94,24 | 48,16 | −534 576 | 32 701 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 322 500 | −3,33 | |||
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 100 | 679 | −85,79 | 47,95 | −196 595 | 32 558 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 000 | 4 779 | −59,43 | 47,34 | −331 380 | 226 238 |
2020-09-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 333 600 | −3,22 | |||
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 750 | 679 | −94,06 | 43,14 | −463 755 | 29 292 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −350 | 11 429 | −2,97 | 42,58 | −14 903 | 486 647 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 344 700 | −3,12 | |||
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 630 | 679 | −87,21 | 43,35 | −200 710 | 29 435 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 470 | 5 309 | −54,93 | 42,63 | −275 816 | 226 323 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 355 800 | −3,03 | |||
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 900 | 679 | −91,04 | 42,91 | −296 079 | 29 136 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 200 | 7 579 | −35,66 | 41,77 | −175 434 | 316 575 |
2020-08-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 366 900 | −2,94 | |||
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 706 | 679 | −71,53 | 40,23 | −68 632 | 27 316 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 194 | 2 385 | −77,46 | 39,62 | −324 646 | 94 494 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 200 | 10 579 | −10,19 | 38,61 | −46 332 | 408 455 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −22 200 | 378 000 | −5,55 | |||
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 380 | 679 | −91,57 | 39,92 | −294 610 | 27 106 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −14 820 | 8 059 | −64,78 | 39,39 | −583 760 | 317 444 |
2020-07-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 22 200 | 22 879 | 3 269,51 | 6,32 | 140 304 | 144 595 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 400 200 | −2,70 | |||
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 743 | 679 | −84,64 | 47,25 | −176 857 | 32 083 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 657 | 4 422 | −60,09 | 46,84 | −311 814 | 207 126 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −700 | 11 079 | −5,94 | 45,36 | −31 752 | 502 543 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 411 300 | −2,63 | |||
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 823 | 679 | −80,61 | 46,38 | −130 931 | 31 492 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 277 | 3 502 | −70,27 | 45,72 | −378 424 | 160 111 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 422 400 | −2,56 | |||
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 600 | 679 | −93,39 | 46,95 | −450 720 | 31 879 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 500 | 10 279 | −12,73 | 46,21 | −69 315 | 474 993 |
2020-06-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 11 779 | 1 634,76 | 6,32 | 70 152 | 74 443 |
2020-05-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −31 372 | 679 | −97,88 | 40,48 | −1 269 939 | 27 486 |
2020-05-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −38 628 | 32 051 | −54,65 | 40,11 | −1 549 369 | 1 285 566 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −11 100 | 433 500 | −2,50 | |||
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 500 | 70 679 | −12,93 | 39,36 | −413 280 | 2 781 925 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −600 | 81 179 | −0,73 | 38,67 | −23 202 | 3 139 192 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 100 | 81 779 | 15,70 | 6,32 | 70 152 | 516 843 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −35 400 | 444 600 | −7,38 | |||
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 158 | 70 679 | −9,20 | 38,11 | −272 791 | 2 693 577 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −22 342 | 77 837 | −22,30 | 37,53 | −838 495 | 2 921 223 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 400 | 100 179 | −5,11 | 36,34 | −196 236 | 3 640 505 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −400 | 105 579 | −0,38 | 35,13 | −14 052 | 3 708 990 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −100 | 105 979 | −0,09 | 33,56 | −3 356 | 3 556 655 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 35 400 | 106 079 | 50,09 | 6,32 | 223 728 | 670 419 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −31 200 | 480 000 | −6,10 | |||
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −28 000 | 70 679 | −28,37 | 35,44 | −992 320 | 2 504 864 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 200 | 98 679 | −3,14 | 34,26 | −109 632 | 3 380 743 |
2020-05-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 31 200 | 101 879 | 44,14 | 6,32 | 197 184 | 643 875 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −25 600 | 511 200 | −4,77 | |||
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −25 500 | 70 679 | −26,51 | 30,28 | −772 140 | 2 140 160 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −100 | 96 179 | −0,10 | 29,63 | −2 963 | 2 849 784 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 25 600 | 96 279 | 36,22 | 6,32 | 161 792 | 608 483 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 900 | 536 800 | −0,72 | |||
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 697 | 70 679 | −3,68 | 29,50 | −79 562 | 2 085 030 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 203 | 73 376 | −1,61 | 28,55 | −34 346 | 2 094 885 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 900 | 74 579 | 5,52 | 6,32 | 24 648 | 471 339 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −14 900 | 540 700 | −2,68 | |||
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 988 | 70 679 | −6,59 | 29,58 | −147 545 | 2 090 685 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 912 | 75 667 | −9,47 | 28,63 | −226 521 | 2 166 346 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 000 | 83 579 | −2,34 | 27,72 | −55 440 | 2 316 810 |
2020-04-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 900 | 85 579 | 21,08 | 6,32 | 94 168 | 540 859 |
2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 400 | 555 600 | −1,31 | |||
2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 600 | 70 679 | −8,54 | 33,53 | −221 298 | 2 369 867 |
2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −800 | 77 279 | −1,02 | 32,85 | −26 280 | 2 538 615 |
2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 400 | 78 079 | 10,47 | 6,32 | 46 768 | 493 459 |
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −7 400 | 563 000 | −1,30 | |||
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 900 | 70 679 | −5,23 | 33,21 | −129 519 | 2 347 250 |
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 500 | 74 579 | −4,48 | 32,18 | −112 630 | 2 399 952 |
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 7 400 | 78 079 | 10,47 | 6,32 | 46 768 | 493 459 |
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −18 500 | 570 400 | −3,14 | |||
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −18 500 | 70 679 | −20,74 | 31,38 | −580 530 | 2 217 907 |
2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 18 500 | 89 179 | 26,17 | 6,32 | 116 920 | 563 611 |
2020-02-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 300 000 | 300 000 | |||||
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 588 900 | −0,62 | |||
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 400 | 70 679 | −3,28 | 28,30 | −67 920 | 2 000 216 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 300 | 73 079 | −1,75 | 27,33 | −35 529 | 1 997 249 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 74 379 | 5,23 | 6,32 | 23 384 | 470 075 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 592 600 | −0,62 | |||
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 300 | 70 679 | −1,81 | 29,54 | −38 402 | 2 087 858 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 300 | 71 979 | −1,77 | 28,98 | −37 674 | 2 085 951 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 100 | 73 279 | −1,48 | 27,80 | −30 580 | 2 037 156 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 74 379 | 5,23 | 6,32 | 23 384 | 470 075 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −3 700 | 596 300 | −0,62 | |||
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 700 | 70 679 | −4,97 | 29,52 | −109 224 | 2 086 444 |
2020-01-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 700 | 74 379 | 5,23 | 6,32 | 23 384 | 470 075 |
2019-07-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Series E-1 Preferred Stock |
C - Conversion | −70 679 | 0 | −100,00 | ||||
2019-07-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
C - Conversion | 70 679 | 70 679 | |||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 100 000 | ||||||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 300 000 | ||||||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 100 000 | ||||||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 300 000 | ||||||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 100 000 | ||||||||
2019-06-26 | 3 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
1 300 000 |